natgillin/translations-raw huggingface dataset:
Priorities will be identified based on the particular needs, potential and level of economic development in the region or country.
Prednostne naloge bodo določene na podlagi posebnih potreb, potenciala in stopnje gospodarskega razvoja v regiji ali državi.
To this end, an international cooperation strategy and implementation plan will be developed with specific targeted actions within or across the themes, e.g. in health, agriculture, sanitation, water, food security, social cohesion, energy, environment, fisheries, aquaculture and natural resources, sustainable economic policy and information and communication technologies.
V ta namen je predviden razvoj mednarodne strategije za sodelovanje in izvedbeni načrt s posebnimi usmerjenimi ukrepi znotraj ali med temami, npr. zdravje, kmetijstvo, sanitarne storitve, voda, varna hrana, družbena kohezija, energija, okolje, ribištvo, ribogojstvo in naravni viri, trajnostna gospodarska politika ter informacijske in komunikacijske tehnologije.
These actions will serve as privileged tools for implementing the cooperation between the Community and these countries.
Ti ukrepi bodo služili kot prednostna orodja za izvajanje sodelovanja med Skupnostjo in temi državami.
These activities will be implemented in coordination with international cooperation actions under the ‘People’ and the ‘Capacities’ specific programmes.
Te dejavnosti se bodo izvajale v povezavi z mednarodnimi ukrepi sodelovanja v okviru posebnih programov „Človeški viri“ in „Zmogljivosti“.
An overall strategy for International Cooperation within the Framework Programme will underpin this activity.
To delovanje bo podprto s celovito strategijo mednarodnega sodelovanja, predvideno v okvirnem programu.
THEMES
TEME
Improving the health of European citizens and increasing the competitiveness and boosting the innovative capacity of European health-related industries and businesses, while addressing global health issues including emerging epidemics.
Izboljšanje zdravja evropskih državljanov ter povečanje konkurenčnosti in krepitev inovativne zmogljivosti evropskih industrijskih sektorjev in podjetij, povezanih z zdravjem, ob obravnavi svetovnih zdravstvenih problemov, vključno s pojavljajočimi se epidemijami.
Emphasis will be put on translational research (translation of basic discoveries in clinical applications including scientific validation of experimental results), the development and validation of new therapies, methods for health promotion and prevention including promotion of child health, healthy ageing, diagnostic tools and medical technologies, as well as sustainable and efficient healthcare systems.
Poudarek bo na translacijskih raziskavah (prenos temeljnih odkritij v klinično prakso, vključno z znanstvenim potrjevanjem rezultatov poskusov), na razvijanju in potrjevanju novih terapij, metod za spodbujanje zdravja in preventivo, vključno s spodbujanjem zdravja otrok, tudi za spodbujanje zdravega staranja, diagnostičnega orodja in medicinskih tehnologij, ter tudi na trajnostnih in učinkovitih sistemih zdravstvenega varstva.
Approach
Pristop
This research will advance our understanding on how to promote good health more efficiently, to reduce the health differences across Europe, to prevent and treat major diseases and to deliver healthcare.
Na podlagi teh raziskav bomo lažje ugotovili, kako na učinkovitejši način spodbujati dobro zdravje, zmanjšati razlike na področju zdravja v Evropi, preprečevati in zdraviti glavne bolezni ter nuditi zdravstveno varstvo.
Basic bio-medical research will be an integral part of this theme; multidisciplinary approaches are of particular importance in the health theme.
Sestavni del te teme bodo biomedicinske raziskave, na področju zdravja pa bodo še posebej pomembni multidisciplinarni pristopi.
This research will help integrate the vast amount of genomics, epidemiological, biological and biotechnology data and develop key technologies for health-related industries with a view to developing knowledge and capacity for intervention.
Te raziskave bodo pomagale vključiti obsežne količine genomskih, edpidemioloških, bioloških in biotehnoloških podatkov in razviti ključne tehnologije za industrijske sektorje, povezane z zdravjem; njihov cilj je ustvarjanje novega znanja in zmogljivosti za posredovanje.
It will foster translational health research, which is essential to ensure practical benefits including the improvement of life quality from bio-medical research.
Pospeševale bodo translacijske zdravstvene raziskave, ki so bistvene za zagotovitev praktičnih koristi biomedicinskih raziskav, vključno za večjo kakovostjo življenja.
It will allow Europe to contribute more effectively to international efforts combating diseases of global importance, as illustrated by the ongoing programme on ‘European and Developing Countries Clinical Trials Partnership’ (EDCTP) for combating HIV/AIDS, malaria and tuberculosis (Article 169).
Evropi bodo omogočile, da učinkoviteje prispeva k mednarodnim prizadevanjem za boj proti boleznim svetovnega pomena, kot je prikazano v tekočem programu Partnerstva evropskih držav in držav v razvoju na področju kliničnih študij (European and Developing Countries Clinical Trials Partnership – EDCTP) za preprečevanje virusa HIV/AIDS-a, malarije in tuberkuloze (člen 169).
It will reinforce health policy-driven research at the European level and especially the comparisons of the models, systems and data of national databases.
Okrepile bodo raziskave, ki jih usmerja zdravstvena politika na evropski ravni, in zlasti primerjave modelov, sistemov in podatkov, shranjenih v nacionalnih podatkovnih zbirkah.
The networking of relevant databases is particularly important in this respect.
V tem pogledu je še posebej pomembno povezovanje ustreznih podatkovnih zbirk v omrežja.
This research will help improve the competitiveness of European healthcare biotechnology and medical technology sectors, where SMEs are the main economic drivers, and pharmaceutical industries.
Te raziskave bodo pomagale izboljšati konkurenčnost evropske biotehnološke industrije na področju zdravstvenega varstva in medicinske tehnologije, kjer predstavljajo glavno gospodarsko gonilno silo MSP, in farmacevtske industrije.
It may include support for the European Technology Platform on Innovative Medicines, aiming at overcoming the research bottlenecks in the drug development process.
Vključujejo lahko podporo evropski tehnološki platformi za inovativna zdravila, da bi premostili raziskovalna ozka grla v procesu razvoja zdravil.
Special attention will be given to bridging the gap between research activities and exploitation by providing support for demonstrating proof of concept and clinical validation.
Posebna pozornost bo namenjena vrzeli med raziskovalnimi dejavnostmi in uporabo rezultatov, ki naj bi jo premostili z zagotavljanjem podpore validaciji koncepta in kliničnemu preverjanju.
This research will also contribute to the development of norms and standards for new advanced therapies (e.g. regenerative medicine) needed to help EU industry face worldwide competition.
Te raziskave bodo prispevale tudi k razvoju normativov in standardov za nove napredne terapije (npr. regenerativno medicino), potrebne za pomoč industriji EU pri soočanju s svetovno konkurenco.
Global leadership in European research and innovation in the field of alternative testing strategies, in particular non-animal methods, should be ensured.
Evropskim raziskavam in inovacijam na področju nadomestnih preskusnih strategij in še zlasti metod, ki ne vključujejo živali, je treba zagotoviti vodilno vlogo v svetovnem merilu.
Gender aspects in research will be considered and integrated in the projects whenever appropriate.
Po potrebi bo v okviru projektov upoštevano in vanje tudi vključeno načelo enakopravnosti spolov pri raziskovanju.
Special attention will be given to communicating research outcomes and engaging in dialogue with civil society, in particular with patient groups, at the earliest possible stage, of new developments arising from bio-medical and genetics research.
Posebna pozornost bo namenjena sporočanju rezultatov raziskav in spodbujanju dialoga s civilno družbo, zlasti s skupinami pacientov, v najzgodnejši fazi o novih razvojnih dosežkih biomedicinskih in genetskih raziskav.
A wide dissemination and use of the results will also be assured.
Zagotovljena bosta tudi učinkovito razširjanje in uporaba rezultatov.
The strategic issues, child health and the health of the ageing population will receive specific attention and will have to be taken into account whenever appropriate across all activities in this theme, with priorities highlighted in the work programme.
Posebna pozornost bo namenjena dvema strateškima vprašanjema, zdravju otrok in zdravju starajočega se prebivalstva, ki bosta obravnavani v okviru vseh dejavnosti v okviru te teme, s prednostnimi nalogami, izpostavljenimi v delovnem programu.
Other multi-disciplinary areas will also be included.
Vključena bodo tudi druga multidisciplinarna področja.
This will ensure a visible and coherent approach to these issues across the Theme, whilst avoiding duplication.
To bo zagotovilo jasen in skladen pristop k tem vprašanjem v celotni temi in onemogočilo podvajanje.
Ethical, legal and socio-economic issues will be taken into account within each of the following activities.Activities
Znotraj vseh dejavnosti se bodo upoštevala etična, pravna in družbeno-ekonomska vprašanja.Dejavnosti
Biotechnology, generic tools and medical technologies for human health
Biotehnologija, generična orodja in medicinske tehnologije za ohranjanje človekovega zdravja
This activity aims at developing and validating the necessary tools and technologies that will make possible the production of new knowledge and its translation into practical applications in the area of health and medicine.
Namen te dejavnosti je razvijanje in potrjevanje potrebnih orodij in tehnologij, ki bodo omogočili pridobivanje novega znanja in njegov prenos v praktične uporabe na področju zdravja in medicine.
High-throughput research: to catalyse progress in developing new research tools for modern biology including fundamental genomics that will enhance significantly data generation and improve data and specimen (bio-banks) standardisation, acquisition and analysis.
Zahtevne proizvodne raziskave: pospeševanje napredka pri razvoju novih raziskovalnih orodij za moderno biologijo, vključno s temeljno genomiko, ki bodo znatno pospešila postopek priprave podatkov ter izboljšala standardizacijo, pridobivanje in analiziranje podatkov in vzorcev (biobanke).
The focus will be on new technologies for: sequencing; gene expression, genotyping and phenotyping; structural and functional genomics; bio-informatics and systems biology; other ‘omics’.
Poudarek bo na novih tehnologijah za: zaporedje, izražanje genov, genotipizacijo in fenotipizacijo; primerjalno in funkcionalno genomiko, bioinformatiko in sistemsko biologijo; druga področja, katerih poimenovanja se končajo na „-omika“.
Detection, diagnosis and monitoring: to develop visualisation, imaging, detection and analytical tools and technologies for bio-medical research, for prediction, diagnosis, monitoring and prognosis of diseases, and for support and guidance of therapeutic interventions.
Odkrivanje, diagnoza in spremljanje: razvoj vizualizacije, upodabljanja, orodij in tehnologij za odkrivanje in analizo na področju biomedicinskih raziskav, napovedovanja, diagnosticiranja, spremljanja in prognosticiranja bolezni ter v podporo terapevtskim posegom in za njihovo vodenje.
The focus will be on a multidisciplinary approach integrating areas such as: molecular and cellular biology, physiology, genetics, physics, chemistry, bio-medical engineering including nano-technologies, microsystems, devices and information technologies.
Poudarek bo na multidisciplinarnem pristopu, ki vključuje področja, kot so: molekularna in celična biologija, fiziologija, genetika, fizika, kemija, biomedicinska tehnologija, vključno z nanotehnologijami, mikrosistemi, napravami in informacijsko tehnologijo.
Non- or minimally-invasive and quantitative methods and quality assurance aspects will be emphasised.
Poudarjene bodo neinvazivne ali minimalno invazivne in kvantitativne metode ter vidiki zagotavljanja kakovosti.
Predicting suitability, safety and efficacy of therapies: to develop and validate the parameters, tools, methods and standards needed for bringing to the patient safe and effective new or improved bio-medicines.
Predvidevanje primernosti, varnosti in učinkovitosti terapij: razvoj in potrjevanje parametrov, orodij, metod in standardov, potrebnih za oskrbo pacientov z varnimi in učinkovitimi novimi ali izboljšanimi bio zdravili.
The focus will be on approaches such as pharmacogenomics, developing and validating biological markers, targeting and delivery approaches, in silico, in vitro (including alternatives to animal testing) and in vivo methods and models.
Poudarek bo na pristopih, kot so farmakogenomika, razvoj in potrjevanje bioloških označevalcev, ciljno usmerjeni pristopi in pristopi oskrbe, metode in modeli in silico, in vitro (vključno z alternativami za preskuse na živalih) ter in vivo.
Innovative therapeutic approaches and interventions: to research, consolidate and ensure further developments in advanced therapies and technologies with broad potential application.
Inovativni terapevtski pristopi in posegi: raziskave, krepitev in zagotavljanje nadaljnjega razvoja naprednih terapij in tehnologij s široko možno uporabo.
The focus will be on gene and cell therapy, regenerative medicine, transplantation, immunotherapy and vaccines, and other medicines.
Poudarek bo na genski in celični terapiji, regenerativni medicini, presaditvah, imunoterapiji in cepivih ter drugih zdravilih.
Related technologies, such as advanced targeted delivery systems, advanced implants and prosthetics, and non- or minimally-invasive technology-assisted interventions will also be addressed.
Prav tako bodo obravnavane podobne tehnologije, kot na primer napredni sistemi za dostavo učinkovin na ciljno mesto, napredni vsadki in protetika ter neinvazivni ali minimalno invazivni tehnološko podprti posegi.
Translating research for human health
Translacijske raziskave, ki služijo človekovemu zdravju
This activity aims to increase knowledge of biological processes and mechanisms involved in normal health and in specific disease situations, to transpose this knowledge into clinical applications including disease control and treatment, and to ensure that clinical (including epidemiological) data guide further research.
Ta dejavnost je namenjena izboljšanju znanja o bioloških procesih in mehanizmih, ki so del normalnega zdravstvenega stanja in posebnega bolezenskega stanja, da bi to znanje prenesli v klinično prakso, vključno z nadzorom bolezni in zdravljenjem, in zagotovili, da bodo nadaljnje raziskave usmerjali klinični podatki (vključno z epidemiološkimi).
Integrating biological data and processes: large-scale data gathering, systems biology.
Vključevanje bioloških podatkov in procesov: zbiranje obsežnejših podatkov, sistemska biologija.
Large-scale data gathering: to use high-throughput technologies to generate data for elucidating the function of genes and gene products and their interactions in complex networks in important biological processes.
Zbiranje obsežnejših podatkov: uporaba zahtevnih proizvodnih tehnologij pri zbiranju podatkov za pojasnjevanje funkcije genov in genskih proizvodov ter njihovih interakcij v kompleksnih mrežah pri pomembnih bioloških procesih.
The focus will be on: genomics; proteomics, ‘RNA-omics’; population genetics; comparative, structural and functional genomics.
Poudarek bo na: genomiki; proteomiki, „RNK-omiki“; populacijski genetiki; primerjalni, strukturalni in funkcionalni genomiki.
Systems biology: the focus will be on multidisciplinary research that will integrate a wide variety of biological data and will develop and apply system approaches to understand and model biological processes in all relevant organisms and at all levels of organisation.
Sistemska biologija: poudarek bo na multidisciplinarnih raziskavah, ki bodo vključevale veliko različnih bioloških podatkov ter bodo razvijale in uporabljale sistemske pristope za razumevanje in oblikovanje bioloških procesov v vseh zadevnih organizmih in na vseh ravneh organizacije.
Research on the brain and related diseases, human development and ageing.
Raziskave možganov in z njimi povezanih bolezni, človekovega razvoja in staranja.
Brain and brain-related diseases: to better understand the integrated structure and dynamics of the brain, and to study brain diseases including relevant age-related illness (e.g. dementia, Parkinson's disease) and search for new therapies.
Možgani in z njimi povezane bolezni: boljše razumevanje integrirane strukture in dinamike možganov, proučevanje možganskih bolezni, tudi s starostjo povezanih obolenj (npr. demence, Parkinsonove bolezni) ter iskanje novih terapij.
The focus will be on gaining a global understanding of the brain by exploring brain functions, from molecules to cognition including neuroinformatics, and brain dysfunction, from synoptic impairment to neurodegeneration.
Poudarek bo prizadevanjih, da bi pridobili celovito znanje o delovanju možganov in sicer z raziskovanjem delovanja možganov od molekul do zaznavanja, vključno z nevroinformatiko in možgansko disfunkcijo, od sinaptičnih sposobnosti do nevrodegeneracije.
Research will address neurological and psychiatric diseases and disorders, including regenerative and restorative therapeutic approaches.
Raziskave bodo vključevale nevrološke in psihične bolezni in motnje, vključno z regenerativnimi in obnovitvenimi terapevtskimi pristopi.
Human development and ageing: use of a wide variety of methodologies and tools to better understand the process of life-long development and healthy ageing.
Človekov razvoj in staranje: uporaba širokega spektra metodologij in orodij za boljše razumevanje procesa vseživljenjskega razvoja in zdravega staranja.
The focus will be on the study of human and model systems, including interactions with factors such as environment, genetics, behaviour and gender.
Poudarek bo na preučevanju človeškega sistema in sistema modelov, vključno z medsebojnim vplivanjem z dejavniki, kot so okolje, genetika, vedenje in spol.
Translational research in major infectious diseases: to confront major threats to public health.
Translacijske raziskave pri glavnih nalezljivih boleznih: soočanje z glavnimi grožnjami javnemu zdravju.
Anti-microbial drug resistance including fungal pathogens: the focus will be on combining basic research on molecular mechanisms of resistance, microbial ecology and host-pathogen interactions with clinical research towards new interventions to reduce the emergence and spread of multi-drug resistant infections.
Odpornost na protimikrobna zdravila, vključno s fungalnimi patogeni: poudarek bo na združevanju temeljnih raziskav molekularnih odpornih organizmov, mikrobiološke ekologije in interakcije med gostiteljem in patogenom s kliničnimi raziskavami v smeri novih intervencij za zmanjšanje možnosti nastajanja in širjenja infekcijskih bolezni, odpornih na več zdravil.
HIV/AIDS, malaria and tuberculosis: the focus will be on developing new therapies, diagnostic tools, preventive tools such as vaccines and chemical transmission barriers such as HIV microbicides.
HIV/AIDS, malarija in tuberkuloza: poudarek bo na razvoju novih terapij, diagnostičnih orodij, preventivnih orodij, kot so cepiva, in kemični prenos ovir, kot so HIV mikrobicidi.
Research efforts will confront the three diseases at global level, but will also address specific European aspects of the three diseases as well as Hepatitis.
Raziskovalna prizadevanja se bodo s temi tremi boleznimi soočila na svetovni ravni, vendar bodo obravnavala tudi posebne evropske vidike treh bolezni in hepatitisa.
Preclinical and early clinical research activities will be emphasised, and where relevant (e.g. for HIV/AIDS vaccines) collaboration with global initiatives is foreseen.
Poudarjene bodo predklinične in zgodnje klinične raziskovalne dejavnosti in, kjer je primerno (npr. za cepiva proti HIV/AIDS-u), je predvideno sodelovanje s svetovnimi pobudami.
Potentially new and re-emerging epidemics: the focus will be on confronting emerging pathogens with pandemic potential including zoonoses (e.g. SARS and highly pathogenic influenza).
Morebitne nove in ponavljajoče se epidemije: poudarek bo na preprečevanju nastajajočih patogenov s pandemičnim potencialom, vključno z zoonozami (npr. SARS in visoko patogena influenca).
Where appropriate, provisions will be made for rapidly initiating collaborative research aimed at expediting development of new diagnostics, drugs and vaccines for efficient prevention, treatment, and control of infectious disease emergencies.
Po potrebi bodo sprejete določbe za hiter začetek skupnih raziskav, namenjenih pospešitvi razvoja novih diagnostik, zdravil in cepiv za učinkovito preprečevanje, zdravljenje in nadzor nad nujnimi primeri nalezljivih bolezni.
Translational research in other major diseases
Translacijske raziskave pri drugih glavnih boleznih
Cancer: the focus will be on disease aetiology, new medicines and therapies; identifying and validating drug targets and biological markers that aid in the prevention, early diagnosis and treatment; and assessing the effectiveness of preventive prognostic, diagnostic and therapeutic interventions.
Rak: poudarek bo na etiologiji bolezni ter novih zdravilih in terapijah; določanju in vrednotenju ciljev zdravil in bioloških označevalcev, ki pomagajo pri preprečevanju, zgodnjem diagnosticiranju in zdravljenju; ter ocenjevanju učinkovitosti preventivnih prognostičnih, diagnostičnih in terapevtskih posegov.
Cardiovascular disease: the focus will be on diagnosis, prevention, treatment and monitoring of heart and blood vessel diseases (including vascular aspects of stroke) using broad multidisciplinary approaches.
Bolezni srca in ožilja: poudarek bo na diagnozi, preprečevanju, zdravljenju in spremljanju bolezni srca in krvnih žil (vključno z vaskularnimi vidiki možganske kapi) ob uporabi obsežnih multidisciplinarnih pristopov.
Diabetes and obesity: for the former, the focus will be on aetiologies of the different types of diabetes, and their related prevention and treatment.
Diabetes in debelost: pri prvem bo poudarek na etiologiji različnih vrst diabetesa in s tem povezanega preprečevanja in zdravljenja.
For the latter, the focus will be on multidisciplinary approaches including genetics, life style and epidemiology.
Pri drugem bo poudarek na multidisciplinarnih pristopih, vključno z genetiko, življenjskim slogom in epidemiologijo.
For both diabetes and obesity, special attention will be given to juvenile diseases and factors operating in childhood.
Pri diabetesu in debelosti bo posebna pozornost posvečena otroškim boleznim in dejavnikom, ki delujejo v otroštvu.
Rare diseases: the focus will be on Europe-wide studies of natural history, pathophysiology and on development of preventive, diagnostic and therapeutic interventions.
Redke bolezni: poudarek bo na vseevropskih študijah prirodoslovja, patofiziologije in na razvoju preventivnih, diagnostičnih in terapevtskih posegov.
This sector will include rare Mendelian phenotypes of common diseases.
V ta del bodo vključeni redki Mendelovi fenotipi splošnih bolezni.
Other chronic diseases: the focus will be on non-lethal diseases with a high impact on the quality of life at old age such as functional and sensory impairment and other chronic diseases (e.g. arthritis, rheumatic and musculo-skeletal diseases and respiratory diseases including those induced by allergies).
Druge kronične bolezni: poudarek bo na nesmrtonosnih boleznih z močnim učinkom na kakovost življenja v starosti, kot so slabšanje funkcionalnih in senzoričnih sposobnosti ter druge kronične bolezni (npr. artritis, revmatične bolezni, mišično-kostne bolezni in bolezni dihalnih organov, vključno z boleznimi, ki jih povzročijo alergije).
Optimising the delivery of healthcare to European citizens
Optimizacija zdravstvenega varstva evropskih državljanov